Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Theorem Executives to Speak at PCT | Contract Pharma

What are you searching for?

Sign in
Breaking News

Theorem Executives to Speak at PCT

Will address clinical data analytics

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Three executives from Theorem Clinical Research will present at the 23rd Annual Partnerships in Clinical Trials in Las Vegas, NV, March 31 – April 2.
 
President and chief executive officer, John Potthoff, will speak on “The Real Impact of Going Public/Private on Business,” 2:00 p.m. – 3:00 p.m. on Monday, March 31. Alison Taber, vice president of global data management, will join a panel discussion on the topic of “Risk-Based Study Management for Small to Midsized Companies,” 2:30 p.m. – 3:30 p.m. on March 31. Also, Mark Penniston, executive vice president and general manager of Clinical Analytics, will discuss visual analytics and real-world applications at 4:30 p.m. on Tuesday, April 1.
           
“The amount of data collected in modern clinical trials can be completely overwhelming unless you have ways to see it that make it meaningful,” Mr. Penniston said. “Theorem has been developing advanced visual analytics tools and techniques that allow us to present complex clinical information graphically, giving you a quicker grasp and greater insight into the meaning the numbers actually represent.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics